David P. Ryan

Bradford Teaching Hospitals NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

91h-index35.0kcitations937works0.92yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(280), Colorectal Cancer Treatments and Studies(150), Cancer Genomics and Diagnostics(143), Gastric Cancer Management and Outcomes(91), Cancer Immunotherapy and Biomarkers(63)

Publications936 total

Co-Designing Research Priorities in Developmental Neuroscience: A Community-Based Participatory Approach

2026Open Access

Supplementary Figure S5 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Figure S3 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Figure S1 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Table S2 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Figure S7 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Figure S4 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Figure S2 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Table S4 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Table S6 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Table S5 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Figure S6 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Table S1 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

Supplementary Table S3 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

2025Open Access

High frequency DOC proxy sensor assessment for peatland streams and across hydrological continua

Journal of Environmental Management·2025Open Access

Concurrent use of substance-use disorder treatment and mental healthcare in rural as compared to urban communities

Drugs Habits and Social Policy·2025

Supplemental Table 3: Pattern 7 Ordered Genes from Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma

2025Open Access

Supplemental Table 1: Pancreas Gene Markers from Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma

2025Open Access

Supplementary Methods and Figures from Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma

2025Open Access

Supplemental Table 2: Pattern 1 Pathways from Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma

2025Open Access

page 1 of 47Next →

Frequent Co-authors

Jeffrey W. Clark(23), Lawrence S. Blaszkowsky(20), Andrew X. Zhu(18), Eunice L. Kwak(14), Theodore S. Hong(13), Charles S. Fuchs(12), Jill N. Allen(11), Peter C. Enzinger(11), Jennifer Y. Wo(10), Cristina R. Ferrone(9), Jeffrey A. Meyerhardt(9), Lipika Goyal(8), Janet E. Murphy(7), Alona Muzikansky(7), Ryan B. Corcoran(7), Ryan David Nipp(7), David T. Ting(6), Keith D. Lillemoe(6), Carlos Fernández‐del Castillo(6), Keith Stuart(6)